Sentence examples for prone to release from inspiring English sources
When aggravated, they are prone to release sheep in inconvenient locations or drive tractors three abreast down motorways.
The findings indicate that the leukocytes are more prone to release and produce MMP-9 in symptomatic and angiographically verified CAD a phenomenon that may have clinical implications in the course of disease.
We have shown that this regulation can be impaired in chronic inflammatory states whereby neutrophils isolated from synovial fluids of rheumatoid arthritis patients are primed and are prone to release high amounts of ROS [18].
Taken together, our data validate our hypothesis that PCCs are prone to release miR-10b as cargo within exosomes.
As one example, degradative lignin analysis methods generally overestimate S-lignin [ 64] since these are less condensed and more prone to release monomers.
However, upon contact with high concentrations of dissolved proteins, such as albumin in serum, the nanoparticles are prone to release the encapsulated TNF- α rapidly, probably being replaced with the proteins outside as reported [ 30] (data not shown).
Studies have shown that an unknown percentage of the population may be prone to releasing a large amount of histamine in response to vancomycin [ 6].
Furthermore, emerging evidence suggests that mature, end-stage amyloid fibers may serve as a reservoir, prone to releasing toxic oligomer (Xue et al., 2009; Cremades et al., 2012; Krishnan et al., 2012; Shahnawaz and Soto, 2012).
They "presented an affidavit from a man who said Professor Hill had mistakenly believed he had a sexual interest in her and was prone to fantasy," releasing to the public a wide array of wild claims that they made no effort to check or verify.
Based on the hypothesis that cell surface exposed glycoproteins are prone to be released from tumor-cells to the circulatory system, we screened the surfaceome of model cell lines for potential MPM candidate biomarkers.
Our findings of circulating YB-1/p18 fragments in plasma of patients with cancer now indicates that dysregulated YB-1 may be prone to be released as fragments into the circulation, which would allow its easy use as a non-invasive disease marker.
